Published 1990 | Version v1
Book

Synthesis and evaluation of 2-(p-isothiocyanatobenzyl)-trans-cyclohexyl-DTPA linked to antibody B72.3 for radioimmunoimaging and therapy

  • 1. National Institutes of Health, Bethesda, MD (USA)

Description

Radioimmunotherapy with the α-emitter Bi-212 chelate linked to antibody is of current interest in oncology. Isothiocyanatobenzyl cyclohexyl-DTPA (CHX-DPTA) was synthesized to incorporate the semi-rigid geometry conferred by the cyclohexyl ring and thereby increase metal complex stability in vivo for therapeutic radionuclides. BOC-p-nitrophenylalanine was converted to the amide of trans-1,2-diaminocyclohexane. After deprotection, the amide was reduced, and the resulting triamine alkylated to the pentaacetic acid. Two pairs of diastereomers were isolated and characterized. Biodistribution results indicate that inclusion of the cyclohexyl structure into a DTPA resulted in an acyclic ligand useful for radioimmunotherapy with either Y-90 or Bi-212

Additional details

Publishing Information

Publisher
American Chemical Society.
Imprint Place
Washington, DC (USA)
Imprint Title
American Chemical Society, Division of Inorganic Chemistry, Inc.
Imprint Pagination
158 p.
Journal Page Range
p. 22-23.

Conference

Title
200. American Chemical Society national meeting.
Dates
26-31 Aug 1990.
Place
Washington, DC (USA).

Optional Information

Notes
Paper INOR 73.
Secondary number(s)
CONF-900802--.